Septra and Temsirolimus drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Septra (sulfamethoxazole; trimethoprim) and Temsirolimus (temsirolimus). Common drug interactions include encephalopathy among females and groin pain among males.

The phase IV clinical study analyzes what interactions people have when they take Septra and Temsirolimus. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Septra?

Septra has active ingredients of sulfamethoxazole; trimethoprim. It is often used in urinary tract infection. eHealthMe is studying from 10,280 Septra users. Check the latest studies of Septra.

What is Temsirolimus?

Temsirolimus has active ingredients of temsirolimus. eHealthMe is studying from 3,573 Temsirolimus users. Check the latest studies of Temsirolimus.

On Jul, 28, 2026

12 people who take Septra and Temsirolimus together, and have interactions are studied.

Septra and Temsirolimus drug interactions.

What are the common drug interactions of Septra and Temsirolimus, by gender? *:

female:

Encephalopathy (functioning of the brain is affected by some agent or condition)
Hypercalcaemia (elevated calcium (ca+) level in the blood)
Hypocalcaemia (levels of calcium in blood serum are abnormally low)
Hypotension (abnormally low blood pressure)
Respiratory failure (inadequate gas exchange by the respiratory system)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
Blood pressure increased
Confusional state
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

male:

Groin pain
Thrombocytopenia (decrease of platelets in blood)
Lobar pneumonia (a form of pneumonia that affects a large and continuous area of the lobe of a lung)
Pneumonia

What are the common drug interactions of Septra and Temsirolimus, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Acidosis (build-up of carbon dioxide in the blood)
Cardiac arrest
Encephalopathy (functioning of the brain is affected by some agent or condition)
Hypercalcaemia (elevated calcium (ca+) level in the blood)
Hypocalcaemia (levels of calcium in blood serum are abnormally low)
Hypotension (abnormally low blood pressure)
Respiratory failure (inadequate gas exchange by the respiratory system)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
Blood pressure increased

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Groin pain
Pneumonia
Thrombocytopenia (decrease of platelets in blood)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Lobar pneumonia (a form of pneumonia that affects a large and continuous area of the lobe of a lung)
Neuropathy peripheral (surface nerve damage)

What are the existing conditions these people have? *

B Precursor Type Acute Leukaemia (lymphoid cancer): 9 people, 75.00%
Klebsiella Infection: 6 people, 50.00%
Pneumonia Klebsiella (pneumonia caused by bacteria klebsiella): 2 people, 16.67%
Nausea (feeling of having an urge to vomit): 1 person, 8.33%
Leukaemia Plasmacytic (a progressive, malignant disease of the blood-forming organs): 1 person, 8.33%
Cough: 1 person, 8.33%
Constipation: 1 person, 8.33%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 8.33%
B-Cell Small Lymphocytic Lymphoma (blood cancer affecting b cells): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Septra and Temsirolimus?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously